lovastatin has been researched along with Age-Related Osteoporosis in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, HF; He, XB; Li, X; Li, ZR; Liu, ZY; Shao, HY; Si, SY; Yang, ZY; Zhang, YQ | 1 |
| Guo, HF; He, XB; Jiang, JD; Li, X; Li, ZR; Liu, ZY; Shao, HY; Si, SY; Xue, ST; Yang, ZY; Zhang, YQ | 1 |
| Guo, HF; Jin, J; Ju, DH; Li, ZR; Liu, MJ; Liu, ZY; Xue, ST | 1 |
| Guo, HF; Jin, J; Li, ZR; Liu, ZY; Xie, ZS; Xue, ST; Yi, H; Zhang, L | 1 |
| Hu, J; Li, T; Liu, X; Sun, F; Wang, D; Wang, F; Yang, X; Ye, X | 1 |
| Kaleağasıoğlu, F; Olcay, E; Onur, R | 1 |
| Abdul-Majeed, S; Mohamed, N; Soelaiman, IN | 1 |
| Ibrahim, N'; Mohamed, N; Shuid, AN; Soelaiman, IN | 1 |
| Chang, SP; Chiang, SS; Pan, TM | 1 |
| Gonyeau, MJ | 1 |
| Jadhav, SB; Jain, GK | 1 |
| Chung, KC; Shen, WJ; Wang, GJ | 1 |
| Boyce, B; Chan, J; Chen, D; Garrett, R; Gutierrez, G; Harris, S; Mundy, G; Rossini, G; Zhao, M | 1 |
| Vogel, G | 1 |
| Abe, K; Asami, S; Kodama, T; Konishi, K; Oikawa, S; Sugiyama, M | 1 |
| Davignon, J; Mabile, L | 1 |
| Yoneda, T | 1 |
4 review(s) available for lovastatin and Age-Related Osteoporosis
| Article | Year |
|---|---|
Statins and osteoporosis: a clinical review.
Topics: Aged; Bone and Bones; Bone Density; Clinical Trials as Topic; Female; Fractures, Bone; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Middle Aged; Osteogenesis; Osteoporosis; Simvastatin; Treatment Outcome; United States | 2005 |
Statins and osteoporosis: new role for old drugs.
Topics: Animals; Atorvastatin; Bone and Bones; Clinical Trials as Topic; Drug Delivery Systems; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Fractures, Bone; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Liver; Lovastatin; Osteogenesis; Osteoporosis; Pharmacokinetics; Pravastatin; Pyridines; Pyrimidines; Pyrroles; Quinolines; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2006 |
[Mechanisms of action of statins and their pleiotropic effects].
Topics: Arteriosclerosis; Cell Division; Endothelium, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lovastatin; Neoplasms; Osteoporosis | 2001 |
[Stimulation of bone formation by anti-hyperlipidemic agent statins and its mechanism of action].
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Indoles; Lovastatin; Mevalonic Acid; Osteogenesis; Osteoporosis; Stimulation, Chemical; Transforming Growth Factor beta | 2002 |
13 other study(ies) available for lovastatin and Age-Related Osteoporosis
| Article | Year |
|---|---|
Synthesis and evaluation of 1-(benzo[b]thiophen-2-yl)ethanone analogues as novel anti-osteoporosis agents acting on BMP-2 promotor.
Topics: Animals; Bone and Bones; Bone Morphogenetic Protein 2; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Design; Female; Gene Expression Regulation; Humans; Mice; Models, Chemical; Osteoporosis; Ovariectomy; Promoter Regions, Genetic; Rats; Thiophenes | 2009 |
Substituted benzothiophene or benzofuran derivatives as a novel class of bone morphogenetic protein-2 up-regulators: synthesis, structure-activity relationships, and preventive bone loss efficacies in senescence accelerated mice (SAMP6) and ovariectomized
Topics: Anabolic Agents; Animals; Benzofurans; Bone Density; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Cell Line; Female; Lethal Dose 50; Male; Mice; Osteoporosis; Ovariectomy; Rats; Stereoisomerism; Structure-Activity Relationship; Thiophenes; Up-Regulation | 2010 |
Synthesis of a novel class of substituted benzothiophene or benzofuran derivatives as BMP-2 up-regulators and evaluation of the BMP-2-up-regulating effects in vitro and the effects on glucocorticoid-induced osteoporosis in rats.
Topics: Animals; Benzofurans; Bone Morphogenetic Protein 2; Cell Line; Female; Glucocorticoids; Male; Mice; Mice, Inbred Strains; Osteoporosis; Rats; Rats, Wistar; Thiophenes; Up-Regulation | 2015 |
Substituted benzothiophene and benzofuran derivatives as a novel class of bone morphogenetic Protein-2 upregulators: Synthesis, anti-osteoporosis efficacies in ovariectomized rats and a zebrafish model, and ADME properties.
Topics: Animals; Benzofurans; Bone Morphogenetic Protein 2; Caco-2 Cells; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Mice; Mice, Inbred BALB C; Molecular Structure; Osteoporosis; Ovariectomy; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiophenes; Zebrafish | 2020 |
Controlling sustained statins release in multi-layered composite scaffolds for healing of osteoporotic bone defects.
Topics: Animals; Bone and Bones; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Osteoporosis; Rabbits; Tissue Scaffolds | 2022 |
Statins as potential agents for the prevention and treatment of osteoporosis.
Topics: Animals; Atorvastatin; Bone Density; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Osteoporosis; Rats; Simvastatin | 2018 |
The use of delta-tocotrienol and lovastatin for anti-osteoporotic therapy.
Topics: Animals; Drug Synergism; Female; Femur; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Osteogenesis; Osteoporosis; Ovariectomy; Rats; Rats, Sprague-Dawley; Vitamin E | 2015 |
The Effects of Targeted Deliveries of Lovastatin and Tocotrienol on Ossification-Related Gene Expressions in Fracture Healing in an Osteoporosis Rat Model.
Topics: Animals; Bone Development; Disease Models, Animal; Drug Administration Routes; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Fracture Healing; Gene Expression; Lovastatin; Osteoporosis; Ovariectomy; Rats; Rats, Sprague-Dawley; Tocotrienols | 2015 |
Osteoprotective effect of Monascus-fermented dioscorea in ovariectomized rat model of postmenopausal osteoporosis.
Topics: Animals; Bone Density; Dioscorea; Diosgenin; Disease Models, Animal; Female; Fermentation; Flavins; Glycine max; Heterocyclic Compounds, 3-Ring; Isoflavones; Lovastatin; Monascus; Osteoporosis; Ovariectomy; Phytoestrogens; Plant Roots; Rats; Rats, Sprague-Dawley | 2011 |
Lipid clearing agents in steroid-induced osteoporosis.
Topics: Animals; Anticholesteremic Agents; Bezafibrate; Glucocorticoids; Hypolipidemic Agents; Lovastatin; Methylprednisolone; Osteoporosis; Rabbits | 1995 |
Stimulation of bone formation in vitro and in rodents by statins.
Topics: Animals; Bone Density; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cell Line; Female; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Mice; Mice, Inbred ICR; Organ Culture Techniques; Osteoblasts; Osteoclasts; Osteogenesis; Osteoporosis; Ovariectomy; Promoter Regions, Genetic; Rats; Recombinant Proteins; Simvastatin; Skull; Transfection; Transforming Growth Factor beta | 1999 |
Cholesterol-lowering drugs may boost bones.
Topics: Animals; Anticholesteremic Agents; Bone Density; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Clinical Trials as Topic; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mice; Osteogenesis; Osteoporosis; Rats; Simvastatin; Transforming Growth Factor beta | 1999 |
Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells.
Topics: Anti-Bacterial Agents; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein 4; Bone Morphogenetic Proteins; Bone Neoplasms; Cloning, Molecular; Disulfides; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Indole Alkaloids; Lovastatin; Mevalonic Acid; Osteoporosis; Osteosarcoma; Pravastatin; Promoter Regions, Genetic; RNA, Messenger; Simvastatin; Transfection; Transforming Growth Factor beta; Tumor Cells, Cultured | 2000 |